Elevated concentrations of circulating progesterone in the immediate postconception period have been associated with an increase in embryonic growth rate, interferon-tau production, and pregnancy rate in cattle and sheep. Much of this effect is likely mediated via downstream effects of progesterone-induced changes in gene expression in the uterine tissues. Using state-ofthe-art endoscopic techniques, this study examined the effect of elevated progesterone on the development of in vitro produced bovine zygotes transferred to the oviducts of heifers with high or normal circulating progesterone concentrations and on the transcriptome of blastocysts developing under such conditions. Simmental heifers (n ¼ 34) were synchronized using a controlled internal drug release (CIDR) device for 8 days, with a prostaglandin F 2alpha analogue administered 3 days before removal of the CIDR device. Only animals exhibiting a clear standing estrus (Day 0) were used. To produce animals with divergent progesterone concentrations, half of the animals received a progesterone-releasing intravaginal device (PRID) on Day 3 of the estrous cycle; the PRID was left in place until embryo recovery. All animals were sampled for blood daily from Day 0 to Day 7. Cleaved embryos were transferred by endoscopy to the ipsilateral oviduct of each recipient on Day 2 and then recovered by nonsurgically flushing the oviduct and the uterus on Day 7.
INTRODUCTION
In ruminants, elevated concentrations of circulating progesterone in the immediate postconception period have been associated with advancement in conceptus development posthatching [1] [2] [3] , an associated increase in interferon-tau production by the conceptus, and an increased likelihood of embryo survival [3] [4] [5] [6] [7] [8] [9] [10] [11] .
Recent studies have examined the relationship between early luteal and midluteal phase concentrations of progesterone and subsequent embryo survival/conception rate; in dairy cows, Stronge et al. [10] reported a positive linear and quadratic relationship between both milk concentrations of progesterone on Days 5-7 postinsemination and between the rate of change in progesterone concentrations from Day 4 to Day 7 and embryo survival rate. These observations were confirmed in beef cattle using serum concentrations of progesterone [12] . Furthermore, some evidence indicates that progesterone supplementation of animals at risk of low embryo survival as a result of insufficient progesterone may be beneficial [13] .
The reported effects of high progesterone on embryo growth are likely mediated via downstream effects of well-described progesterone-induced changes in gene expression in the uterine endometrium [3, 14, 15] , leading to changes in histotroph composition, to which the developing embryo is directly exposed [16] . We recently reported a lack of an effect of progesterone exposure during in vitro embryo culture on blastocyst formation in vitro or on conceptus elongation after embryo transfer to synchronized recipients [17] . Interestingly, however, transfer of a blastocyst to a uterine environment previously primed by elevated progesterone resulted in a significant advancement in conceptus elongation consistent with an indirect effect of progesterone on the embryo via the endometrium [17] .
In addition, we recently reported that whereas elevating the circulating progesterone concentrations in vivo by insertion of a progesterone-releasing intravaginal device (PRID) on Day 3 significantly increased the size of the posthatching conceptus, which is consistent with other reports [2, 3] , no effect of elevated progesterone was found on the proportion of embryos at the expected stage of development on Day 5 (16-cell to morula stage) or Day 7 (blastocyst stage) [1] . This led to the hypothesis that the previously reported posthatching advancement in development associated with elevated progesterone [1] [2] [3] may results, at least in part, from progesterone-induced changes in the transcriptome of the early prehatching embryo, the effects of which are only manifested during elongation. To test this hypothesis in single-ovulating animals would be impractical because of the tiny amount of mRNA recoverable from each embryo. In addition, using superovulation as a means of generating more embryos per animal is not possible because of the unavoidable, dramatic increase in progesterone concentration associated with multiple corpora lutea [18] . We therefore combined state-of-the-art endoscopic embryo transfer techniques [19, 20] with our previously validated model for elevating progesterone concentrations in vivo [1] to examine the effect on blastocyst development of transferring in vitro produced bovine embryos to the oviducts of cattle with high or normal circulating progesterone concentrations (and so confirm our previous observations regarding the effect of elevated progesterone on embryo developmental competence) and to compare the transcriptome profile of blastocysts recovered from heifers with normal or elevated circulating progesterone (to determine if posthatching differences in elongation could be explained, in part, by earlier induced differences in embryo gene expression).
MATERIALS AND METHODS
All experimental procedures involving animals were licensed by the Department of Health and Children, Ireland, in accordance with the Cruelty to Animals Act (Ireland 1897) and the European Community Directive 86/609/EC and were sanctioned by the Animal Research Ethics Committee of University College Dublin.
Oocyte Recovery and In Vitro Maturation
Bovine ovaries were obtained from a local slaughterhouse and transported to the laboratory within 2-3 h after slaughter in a thermos flask containing a 0.9% saline solution at 378C. Cumulus-oocyte complexes (COCs) were aspirated from follicles (diameter, 2-8 mm) with an 18-gauge needle, and those COCs with multiple layers of cumulus cells were selected for in vitro maturation. The selected COCs were washed in maturation medium (modified Parker medium) supplemented with 12% estrous cow serum, 0.5 mM Lglutamine, 0.2 mM pyruvate, 50 lg/ml of gentamicin sulfate, and 10 ll/ml of follicle-stimulating hormone (Folltropin; Vetrepharm) before placement in culture. COCs were cultured in groups of 50 in 400 ll of maturation medium under mineral oil in four-well dishes (Nunc) for 24 h at 398C under a humidified atmosphere of 5% CO 2 in air.
In Vitro Fertilization
After maturation, COCs were transferred into four-well dishes containing 400 ll of fertilization medium (Fert-TALP [21] ) supplemented with 2 lg/ml of heparin (Sigma), 0.2 mM pyruvate (Sigma), and 25 ll/ml of penicillinamine, hypotaurine, and epinephrine. A swim-up procedure was used to obtain a motile sample of sperm from frozen-thawed semen [21] . Briefly, frozen-thawed sperm cells from a single selected bull were incubated in a tube containing 1.5 ml of sperm-TALP supplemented with 6 mg/ml of bovine serum albumin and 10 mM pyruvate for 50 min at 398C in a humidified incubator with 5% CO 2 . After this, the supernatant was recovered and centrifuged at 250 3 g for 10 min at room temperature to recover motile sperm cells. In vitro fertilization was performed using a final concentration of 2 3 10 6 sperm cells/ml in the fertilization drop containing a group of 50 COCs. Spermatozoa and matured oocytes were coincubated for 20 h under the same temperature and atmospheric CO 2 content as used for maturation.
Endoscopic Transfer of Embryos
Approximately 20 h postinsemination (hpi), presumptive zygotes were denuded of any residual cumulus cells and attached spermatozoa by vortexing for 90 sec in CR1 culture medium and subsequently cultured in groups of 50 in four-well dishes, each containing 400 ll of CR1aa medium [22] , until Day 2 (48-50 hpi). Cleaved embryos were randomly allocated for in vivo transfer to recipients with normal or elevated progesterone concentrations (see below).
Preparation of Recipient Animals
Embryos, in groups of approximately 100, were transferred into the oviducts of 15-to 24-mo-old Simmental recipients weighing 420-480 kg (n ¼ 34). Animals were presynchronized by application of 500 lg of cloprostenol (synthetic analog of prostaglandin F 2a ; Estrumate; Essex Tierarznei) and subsequent treatment with 8 lg of gonadotropin-releasing hormone (Receptal; Hoechst Roussel Vet GmbH) 2 days after the cloprostenol. This application scheme was repeated within 11 days. Finally, on Day 5 after heat detection, the classical Ovsynch treatment [23] was used to synchronize follicle growth and luteal activity for the temporal in vivo culture of manipulated embryos.
To produce recipients with divergent progesterone concentrations, approximately half of the animals (n ¼ 16) received a PRID on Day 3 of the estrous cycle; this device was left in place until embryo recovery [1] . Embryos were transferred to the oviducts on Day 2 of the estrous cycle as described previously [24] . For transfer, recipients were restrained and received an epidural anesthetic (3.5 ml of 2% lidocaine solution; Selectavet). The tip of a bitubular endoscopic set (Storz) containing the endoscope and the transfer system was placed in the peritoneal cavity via the fornix of the vagina. After passive air movement into the cavity, the reproductive organs were assessed in terms of suitability for embryo transfer. The transfer was performed ipsilateral to the ovary carrying the ovulation site. The transfer system consisted of a 1-ml syringe embedded into a manual dosemeter (IVFETflex.com) and connected to a perfusor tube (no. 701908; Braun). A fire-polished and curved, 50-ll glass capillary (Brand) was attached to the end of the perfusor tube. Approximately 100 cleaved, Day 2 embryos were loaded into the tip of the glass capillary and transferred via the infundibulum into the ampulla.
Five days later, on Day 7 of the estrous cycle, embryos were recovered by endoscopic flushing of the oviduct and uterine horns. Accessing the oviduct was performed as described above. The glass capillary used for transfer was replaced by a silicon-covered flushing metal tube. From 40 to 60 ml of PBS supplemented with 1% fetal calf serum were flushed through the oviducts and uterine horns and collected via an embryo flushing catheter in an embryo filter (Em Con, no. 04135; Immuno Systems, Inc.). A further 300 to 400 ml were used for additional flushing of the uterine horns. Embryos were located under a stereomicroscope. The number of embryos developing to the blastocyst stage was recorded immediately after recovery and following overnight culture in CR1aa medium. Viable Day 7 embryos were washed twice in PBS and snapfrozen in cryotubes, in groups of 10, in a minimal amount of lysis buffer (0.8% Igepal [Sigma] , 40 U/ll of RNasin [Promega] , and 5 mM dithiothreitol [Promega] ). The effect of progesterone treatment on recovery rate and proportion of oocytes developing to the blastocyst stage was analyzed by ANOVA.
Blood Sampling and Progesterone Assay
Daily blood samples were collected from each animal from the day of embryo transfer (Day 2) until the day of embryo recovery (Day 7) by jugular venipuncture. Following collection, blood samples were refrigerated (48C) for 12-24 h before being centrifuged at 1500 3 g at 48C for 20 min. Serum was separated and stored at À208C until assayed to determine progesterone concentration by time-resolved fluoroimmunoassay using an AutoDELFIA Progesterone Kit (PerkinElmer, Wallac Oy). The intra-assay coefficient of variation was 6.8% (high), 5.2% (medium), and 10.0% (low). The sensitivity of the assay was 0.01 ng/ml.
RNA Extraction for Microarray Analysis
Blastocysts were pooled within treatment to generate 10 pools for RNA extraction (five normal pools and five high-progesterone pools). The number of embryos per pool was 68.6 6 5.23 (mean 6 SEM; range, 61-77). Total RNA was prepared from each of the 10 samples using an RNeasy Micro Kit (Qiagen) according to the manufacturer's instructions. The concentration (ng/ll) and the quality of the extracted total RNA were assessed using the Agilent Bioanalyzer 2100 (Agilent Technologies).
Target Preparation and Microarray Processing
For cDNA synthesis, 100 ng of total RNA were used in the first cycle using the GeneChip Expression 3 0 -Amplification Two-Cycle cDNA Synthesis Kit (Affymetrix) in conjunction with the GeneChip Eukaryotic Poly A RNA 708 CARTER ET AL.
Control Kit (Affymetrix). After the first-cycle cDNA synthesis, the MEGAscript T7 Kit (Ambion) was used for the first-cycle in vitro transcription (IVT) amplification to generate unlabeled cRNA. Cleanup of the unlabeled cRNA was carried out using the GeneChip IVT cRNA Cleanup Module (Affymetrix). The unlabeled cRNA was reverse transcribed in the second-cycle, first-strand cDNA synthesis, and subsequently, double-strand cDNA was synthesized using the GeneChip Expression 3 0 -Amplification Two-Cycle cDNA Synthesis Kit. Cleanup of the double-stranded cDNA was carried out using the GeneChip Sample Cleanup Module (Affymetrix). The resulting double-stranded cDNA was amplified and labeled using the GeneChip Expression 3 0 -Amplification IVT Labeling Kit (Affymetrix). To determine the accurate concentration and purity of the newly synthesized, biotin-labeled cRNA, a cleanup step was carried out to remove unincorporated nucleoside triphosphates using the GeneChip Sample Cleanup Module. The cRNA quality was assessed using an Eppendorf Biophotometer and an Agilent 2100 Bioanalyzer.
Next, 25 lg of cRNA generated in the IVT reaction were fragmented using 53 Fragmentation Buffer and RNase-free water contained within the GeneChip Sample Cleanup Module. The fragmentation reaction was carried out at 948C for 35 min to generate 35-200 base fragments for hybridization. The fragmented cRNA quality was assessed using an Agilent 2100 Bioanalyzer.
Before hybridization on the GeneChip Bovine Genome Array (Affymetrix), the adjusted cRNA yield in the fragmentation reaction was calculated to account for carryover of total RNA in the IVT reaction. Fifteen micrograms of fragmented cRNA were made up into a hybridization cocktail in accordance with the Affymetrix technical manual and corresponding to a 49 format (standard)/64 format array. The hybridization cocktail was added to the appropriate array and hybridized for 16 h at 458C. The array was washed and stained on the GeneChip Fluidics Station 450 (Affymetrix) using the appropriate fluidics script; once completed, the array was inserted into the Affymetrix autoloader carousel and scanned using the GeneChip Scanner 3000 (Affymetrix).
Microarray Data Analysis
The GeneChip Bovine Genome containing 24 072 probe sets was used, which allowed monitoring of approximately 23 000 transcripts, including assemblies from approximately 19 000 UniGene clusters. The 10 arrays were first processed using GCOS Software (Affymetrix). Then, expression data from each array were analyzed using GeneSpring software (Agilent Technologies), and data were globally normalized per chip to the median and on a per-gene basis to the normal (control) progesterone samples. Genes were filtered based on Affymetrix Flag calls followed by cross-gene error modeling and, finally, fold-filtering. A list was compiled of genes that were greater than twofold regulated (less stringent list). These data were log transformed, and a Benjamini-Hochberg multiple-testing correction for false-discovery rate (P , 0.05) was applied, leading to a more stringent gene list. Moreover, the gene ontology (GO) analysis of those genes found to be differentially expressed was performed using the functional annotation tool of DAVID (Database for Annotation, Visualization, and Integrated Discovery, http://david.abcc.ncifcrf. gov/). This software tool enables systematic mining of the functional information associated with the generated microarray data and analysis for overrepresentation in the GO biological process, molecular function, and cellular component classifications. Finally, the lists of differentially regulated genes were subjected to KEGG pathway analysis using EASE (Expression Analysis Systematic Explorer) software [25] .
Validation of Results in Single-Ovulating Animals
To validate the results of the microarray analysis described above, quantitative real-time PCR (qPCR) was carried out on Day 7 bovine embryos derived from single-ovulating animals (n ¼ 30) with normal or elevated progesterone. Estrous cycles of cross-bred beef heifers were synchronized as described above, and only animals in standing estrus were used. As above, to produce recipients with divergent progesterone concentrations, half of the animals received a PRID on Day 3 of the estrous cycle; this device was left in place until slaughter on Day 7 [1] . Blood samples were collected daily from each animal by jugular venipuncture from Day 0 to Day 7 to confirm elevation in progesterone concentrations.
Eight transcripts were selected from the list of differentially expressed genes of the array for validation (SLC14A, ZNF470, THBD, TM4SF1, CYP3A, PAG2, CAV1, and CYP11A1). The details of the primers, including primer sequences and product sizes, are described in Table 1 .
RNA Isolation and cDNA Synthesis for qPCR
Messenger RNA was extracted individually from five embryos per treatment (normal or high progesterone) using Dynabeads mRNA DIRECT Micro Kit (Invitrogen Dynal AS) following the manufacturer's instructions. The individually frozen embryos were lysed in the supplied lysis/binding buffer and incubated with prewashed magnetic Dynabeads that can base pair with poly(A) tails of mRNA molecules. Following hybridization and subsequent repeated washes with washing buffers A and B, the RNA was eluted in RNasefree water and reverse transcribed into cDNA using random hexamers and the SuperScript III Reverse Transcription Kit (Invitrogen) in a final reaction volume of 20 ll. As a control, sample that contained all cDNA synthesis ingredients with omitted template or reverse transcriptase enzyme was included. The cDNA synthesis reaction was carried at 508C for 1 h, followed by heat inactivation of the enzyme at 758C for 10 min. After cDNA synthesis, 1 ll of each sample cDNA was taken for PCR to check the cDNA synthesis and purity with primer designed to span intron sequences.
Primer Design and Sequence Analyses
Sequences of eight selected genes from the microarray differentially regulated gene list and of two reference genes were used for primer design. 
PROGESTERONE AND EMBRYO DEVELOPMENT
Primers were designed using Primer Express Software V2 (Applied Biosystems) and optimized before quantification experiments. For these genes (Table 1) , the expected product sizes were confirmed by gel electrophoresis on a 2% agarose gel.
Quantitative Real-Time PCR Reaction Conditions and Analysis
During quantification of the transcripts, the assay for each gene consisted of five replicates per treatment and negative controls. All quantifications were performed consecutively, without interruption. Each sample in a run consisted of 0.15 embryo equivalent cDNA template, 15 pmol of each primer, and 50% SYBR GREEN PCR Master Mix (Applied Biosystems) in a 15-ll reaction volume. The reaction conditions were template denaturation and polymerase activation at 958C for 10 min, followed by 45 cycles of 958C denaturation for 15 sec and 608C annealing and extension for 1 min. All reactions were carried out using the 7300 Real-Time PCR systems machine (Applied Biosystems). At the end of PCR reactions, melting-curve analysis was performed for all the genes to check the specificity of the products. For calculating PCR efficiencies, standard curves were generated from assays made with threefold serial dilutions of five pooled blastocyst cDNA preparations. To ensure the compatibility of PCR assays, three independent serial dilutions were analyzed that enabled us to determine the cycle threshold values and PCR efficiencies of the individual assay and then calculate the correlation between them.
Interaction of Progesterone-Regulated Genes in the Embryo and Endometrium
To examine any potential interactions between progesterone-regulated genes in the embryo and those in the maternal endometrium, we compared the list of progesterone-regulated genes in the Day 7 blastocyst (present study) with our previously published data on progesterone-regulated genes in the endometrium on Day 7 of pregnancy (using the same model for elevating progesterone [15] ) using Ingenuity Pathway Analysis (version 8.5; Ingenuity Systems). The combined lists of differentially expressed genes were submitted to the Ingenuity Knowledge Database for identification of networks, pathways, and interactions between the embryo and endometrium. The combined gene list was overlaid over canonical pathways to identify any possible relationship and interaction among embryo and endometrial genes. Network analysis was also performed to identify networks depicting potential interactions between embryo and endometrial genes.
RESULTS
Insertion of a PRID on Day 3 lead to a rapid, significant increase (fourfold; P , 0.05) in progesterone concentration between control and treated heifers from the day following insertion to Day 7 (Fig. 1) .
Overall, 3641 cleaved embryos were transferred to the oviducts of 34 recipient heifers. The recovery rate on Day 7 was 79% (2869/3641) and was not affected by replicate or by progesterone treatment (Table 2 ). Approximately 52% (n ¼ 1488) of recovered embryos were at the blastocyst stage. These were immediately snap-frozen in liquid nitrogen for RNA extraction. Following subsequent culture of the remaining embryos for 2 days, a further 207 blastocysts appeared. However, the lack of difference (P . 0.05) between the two treatment groups remained in terms of the proportion of embryos reaching the blastocyst stage ( Table 2) .
Of the 24 072 probe sets spotted on the Affymetrix array, approximately 58% were detected as present in the replicate slides. Of these, further analysis for the differentially expressed genes identified 191 genes with greater than 1.5-fold expression (114 down-regulated, 77 up-regulated) in embryos cultured in the oviducts of heifers with high progesterone compared to normal progesterone. Thirteen of these genes were found to be greater than twofold regulated (Tables 3 and 4) .
The lists of differentially expressed genes were subjected to further analysis to determine the functional classifications as assigned by GO terms for overrepresentation. Overrepresentation analysis does not evaluate gene expression levels but, instead, groups genes according to processes that occur more often in the gene list of interest than could be predicted by the distribution among all genes for a particular process represented on the array. To search for important GO biological clusters that may serve to explain the functional roles of differentially regulated genes and their cellular localizations, the differentially expressed genes were classified according to their GO: molecular function, cellular component, and biological process. A high proportion of differentially expressed genes fell into the biological process GO categories relating to cellular metabolic process and biosynthetic process. These two classification categories account for approximately 46% of the differentially regulated genes. Also, other important categories were genes classified to the regulation of biological activity and response to stress, each of which accounted for 9% of the total differentially regulated genes ( Fig. 2A) . Cellular component categorization of the differentially expressed genes revealed that the majority of these genes were localized to the intracellular parts of the cell, with the remaining genes annotated as membrane bound (Fig. 2B) . With regard to molecular function, approximately 75% of the genes were annotated to binding, with binding of cofactor, vitamins, and amine accounting for 33%, 25%, and 17%, respectively (Fig.  2C) . Pathway analysis of progesterone-induced, differentially expressed genes indicated that genes involved in metabolic pathway, mitogen-activated protein kinase signaling, cytokinecytokine receptor interaction, and steroid hormone biosynthesis were prominently up-regulated in high-progesterone animals. However, some genes on the metabolic pathway related to glycine, serine, and threonine metabolism were among the down-regulated genes in response to progesterone induction ( Table 5 ).
Validation of the Microarray Results
To validate the results of the microarray with an independent analysis, we used qPCR to examine a subset of genes from the differentially regulated gene list. Eight transcripts were selected from the list of differentially expressed genes to validate the array results using embryos derived from single-ovulating animals. Progesterone profiles indicated that treated animals had responded to the PRID treatment as expected, with a significant increase in serum progesterone concentration within a day of PRID insertion (data not shown). The results were analyzed using the relative standard curve method, and the expression levels of the target genes were normalized to the averages of the reference genes H2AFZ and PPIA. Although in some cases the results of the qPCR differences were not significant, the pattern of all eight transcripts mirrored that seen on the arrays in terms of the direction of the change (up-or down-regulated) (Fig. 3) .
Interaction of Progesterone-Regulated Genes in the Embryo and Endometrium
The top networks associated with the combined list of progesterone-regulated genes in the embryo and endometrium on Day 7 were 1) lipid metabolism, small molecule biochemistry, vitamin and mineral metabolism (Fig. 4) ; 2) cell cycle, skeletal and muscular system development and function, tissue morphology; and 3) DNA replication, recombination, and repair, nucleic acid metabolism, small molecule biochemistry. The top canonical pathways represented by the combined gene list were coagulation system, glycosphingolipid biosynthesis, and platelet-derived growth factor (PDGF) signaling.
DISCUSSION
Progesterone is a key hormone in the establishment and maintenance of pregnancy. Its role in regulating endometrial gene expression is well documented in ruminants [3, 14, 15, 26] and other species [27, 28] . Evidence from cattle studies has demonstrated a correlation between progesterone concentrations in milk and blood during the first few days after conception and the likelihood of embryo survival.
Based on a small number of embryos, a previous study from our group in single-ovulating animals [1] did not provide any evidence for an effect of elevated progesterone in vivo on the development of the prehatching embryo but did demonstrate an advancement in posthatching elongation (on Days 13 and 16) Bt.13198.1.S1_at
Signal-regulatory protein alpha CK776354 ALAS2 consistent with previous studies [2, 3] . More recently, we have shown that addition of progesterone to culture medium does not affect the proportion of in vitro matured/in vitro fertilized zygotes developing to the blastocyst stage in vitro and does not affect conceptus elongation following transfer to synchronized recipient heifers [17] , suggesting that the progesteroneassociated advancement in conceptus elongation [1] [2] [3] is not the result of a direct effect on the embryo. This conclusion is further supported by the fact that elevating progesterone in vivo for a short period before embryo transfer results in a fourfold increase in conceptus length on Day 14 [17] ; given that the embryo was not present during the period of elevated progesterone, this points to an endometrium/histotroph-mediated effect on conceptus elongation. Whether the maternal environment can induce changes in the transcriptome of the blastocyst, which subsequently exhibits advancement in elongation, is unknown.
In the present study, we used a combination of in vitro embryo production and in vivo culture to confirm, using a large number of embryos, our previous observations in singleovulating animals [1] in terms of progesterone effects on blastocyst development. We used a previously validated method of elevating progesterone from Day 3 to Day 7 of the estrous cycle, around the time when elevated progesterone in vivo has been reported to be associated with increased embryo survival. To our knowledge, this is the first time that the effect of elevated progesterone on early embryo development in vivo has been examined in a meaningful way, with approximately 4000 embryos being transferred to the ipsilateral oviducts of heifers with normal or elevated progesterone. We used a stateof-the-art endoscopic method to transfer groups of zygotes to the oviducts of synchronized recipients. More than 80% of the embryos placed in the oviducts were recovered, and on average, 50% developed to the blastocyst stage, validating the technique. Consistent with our previous observations in vivo [1] and in vitro [17] , elevating progesterone did not affect the proportion of embryos developing to the blastocyst stage. This would support the notion that the early embryo is somewhat autonomous for at least the first week of life and that direct contact with the maternal reproductive tract is, to a certain extent, unnecessary. In support of this, it is possible to routinely transfer in vitro derived, Day 7 embryos to synchronized recipients and obtain acceptable pregnancy rates. Indeed, pregnancies have resulted from the transfer of embryos at Day 12 [29] and even as late as Day 16 [30] . Furthermore, when we compared the transcriptome of the endometrium in pregnant and cyclic heifers on various days from estrus (Days 5, 7, 13, and 16), we could only detect differentially expressed genes in endometrial gene expression on Day 16, coincident with a filamentous embryo secreting a large amount of interferon-tau [15] . This would suggest that the temporal changes occurring in the endometrium are similar in pregnant and cyclic cows up to the point when luteolysis normally occurs.
Taken together, these results indicate that progesterone does not affect the ability of the embryo to reach the blastocyst stage, but they do not preclude the possibility that the observed morphological difference at the elongation stages [1] [2] [3] is the result of progesterone-induced changes in gene expression during the early cleavage stages, which are manifested later by an advancement in growth. To test the hypothesis that exposure to elevated concentrations of progesterone in vivo (or the consequences of such elevated concentrations in terms of histotroph composition) would lead to alterations in the transcriptome of the blastocyst, which in turn would be associated with advanced posthatching elongation, we carried out a microarray analysis of Day 7 blastocysts recovered from 
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animals with normal or elevated progesterone. The results indicated that subtle changes in the blastocyst transcriptome occurred in association with elevated progesterone; 191 probe sets were found to be greater than 1.5-fold differentially expressed. To corroborate the microarray results, and also overcome any potential criticism that the transfer of multiple embryos to the oviducts would result in a nonphysiological environment, we subsequently tested eight selected transcripts in embryos derived from single-ovulating animals with normal or elevated progesterone levels. Whereas the patterns of expression were similar and differences significant (P , 0.05) for the genes SLC1A4, ZNF470, THBD, and TM4SF1, the direction of the change for the remaining transcripts (CYP3A, PAG2, CAV1, and CYP11A1) mirrored that seen in the microarray analysis. THBD is a cell-surface thrombin receptor and component of the thrombomodulin-protein C system that was recognized in controlling the growth and survival of trophoblast cells in the placenta, a function essential for maintenance of pregnancy [31] ; it is also recognized as one of the progesterone-regulated implantation-related genes [32] . Similarly, caveolin-1 is a 22-kDa integral membrane protein implicated in a variety of cellular functions, including transport of cholesterol and small molecules into the cell and intracellular signal transduction [33] . A positive relationship of progesterone and caveolin-1 levels has been previously described [34] . In agreement with our results, the inverse relationship of progesterone signaling and TM4SF1 expression was described in a previous transcriptional profiling study [35] . SLC1A4 is a neutral amino acid transporter. It and other members of this family are differentially expressed in a temporal and cell-specific manner in the uterus and developing conceptus [16] ; in the latter, expression of several transporters, including SLC1A4, was much greater in endoderm than in trophectoderm of ovine conceptuses, where they may function to transport amino acids to meet requirements of the inner cell mass [16] . Finally, to examine any potential interactions between progesterone-regulated genes in the embryo and those in the maternal endometrium, we compared the list of progesteroneregulated genes in the Day 7 blastocyst (present study) with our previously published data on progesterone-regulated genes in the endometrium on Day 7 of pregnancy (using the same model for elevating progesterone [15] ). The top networks associated with the combined list of progesterone-regulated genes in the embryo and endometrium on Day 7 were 1) lipid metabolism, small molecule biochemistry, vitamin and mineral metabolism; 2) cell cycle, skeletal and muscular system development and function, tissue morphology; and 3) DNA replication, recombination, and repair, nucleic acid metabolism, small molecule biochemistry. The top canonical pathways represented by the combined gene list were coagulation system, glycosphingolipid biosynthesis, and PDGF signaling. Given that conceptus elongation is primarily a maternally driven process, as evidenced by the failure of blastocysts to elongate normally in vitro [36, 37] and the absence of elongated conceptuses in uterine gland knockout sheep [38] , this approach will be used in the future to screen the available embryo and endometrial transcriptomic data to determine if direct and/or indirect interactions occur between endometrial-derived ligands and receptors on the conceptus and identify what maternally derived factors are critical for conceptus growth and development.
In conclusion, the present results confirm our previous observations in single-ovulating animals [1] that elevated progesterone does not affect the proportion of embryos developing to the blastocyst stage. This is also consistent with our observations on the effect of adding progesterone to embryo culture medium in vitro [17] . These results suggest that posthatching differences in elongation induced by elevated progesterone may be associated with subtle alterations in the transcriptome at the blastocyst stage. However, whether the changes observed have a functional significance or simply reflect the plasticity of the embryonic transcriptome in adapting transiently to a modified environment remains to be elucidated. In support of a functional role, a recent study by Gad et al. [39] examined the transcriptome of Day 7 blastocysts recovered from superovulated versus nonstimulated heifers and reported 454 differentially expressed genes using the same Affymetrix platform. Although superovulation would lead to supraphysiological progesterone concentrations, these data would support the notion that progesterone-induced changes in the uterine microenvironment can influence the transcriptome of the blastocyst. 
